Valuation dashboard for SeaStar Medical Holding Corporation (ICU) with P/E N/A, P/B 3.00, EV/EBITDA -0.11 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Healthcare companies.
SeaStar Medical Holding Corporation is a medical device company dedicated to providing innovative solutions and services designed to combat hyperinflammation and cytokine storm in critically ill individuals.
Analysis Summary
Trailing-twelve-month margins: gross margin 92.6%, operating margin -8.2%, net margin -8.0%.
At the current price of $3.08, ICU has negative trailing earnings (P/E not meaningful) and an ROE of -162.75%. Market capitalisation stands at $9M.
Balance sheet quality for ICU: current ratio of 3.6. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 3.00 |
| EV / EBITDA | -0.11 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| ICU | SeaStar Medical Holding Corporation | $9M | 3.00 | -162.8% | |
| 0QZU.L | Vertex Pharmaceuticals Incorporated | $131.8B | |||
| VRTX | Vertex Pharmaceuticals Incorporated | $130.3B | 29.68 | 6.45 | 23.3% |
| 0R2M.L | Regeneron Pharmaceuticals, Inc. | $84.0B | |||
| REGN | Regeneron Pharmaceuticals, Inc. | $79.8B | 18.79 | 2.57 | 13.8% |
| ARGX | argenx SE | $61.2B | 36.30 | 7.40 | 21.7% |
| MRNA | Moderna, Inc. | $57.8B | 1.34 | -39.2% | |
| RVMD | Revolution Medicines, Inc. | $41.7B | 15.96 | -96.4% |
Price
| Price | $3.08 |
| Market Cap | $9M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -162.75% |
| Return on Invested Capital | -325.63% |
| Return on Assets | -157.56% |
| Gross Margin | 92.64% |
| Operating Margin | -816.64% |
| Net Margin | -795.50% |
Related companies: ADTX · AIMD · APLM · ATHA · BLRX · CTXR · LNAI
Explore sector: Healthcare · Biotechnology
More sections of ICU: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks